Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Proton magnetic resonance spectroscopy and thought disorder in childhood schizophrenia.

Seese RR, O'Neill J, Hudkins M, Siddarth P, Levitt J, Tseng B, Wu KN, Caplan R.

Schizophr Res. 2011 Dec;133(1-3):82-90. doi: 10.1016/j.schres.2011.07.011. Epub 2011 Aug 27.

2.

Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy.

Woermann FG, McLean MA, Bartlett PA, Barker GJ, Duncan JS.

Brain. 2001 Feb;124(Pt 2):427-36.

PMID:
11157569
3.

Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.

Bertolino A, Kumra S, Callicott JH, Mattay VS, Lestz RM, Jacobsen L, Barnett IS, Duyn JH, Frank JA, Rapoport JL, Weinberger DR.

Am J Psychiatry. 1998 Oct;155(10):1376-83.

PMID:
9766769
4.

1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.

O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR.

Neuroimage. 2004 Apr;21(4):1781-9.

5.

Proton Chemical Shift Imaging of the Brain in Pediatric and Adult Developmental Stuttering.

O'Neill J, Dong Z, Bansal R, Ivanov I, Hao X, Desai J, Pozzi E, Peterson BS.

JAMA Psychiatry. 2017 Jan 1;74(1):85-94. doi: 10.1001/jamapsychiatry.2016.3199.

PMID:
27893013
6.

Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: a (1)H spectroscopy study.

Keshavan MS, Dick RM, Diwadkar VA, Montrose DM, Prasad KM, Stanley JA.

Schizophr Res. 2009 Nov;115(1):88-93. doi: 10.1016/j.schres.2009.08.012. Epub 2009 Sep 11.

PMID:
19748228
7.

Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.

Bustillo JR, Jones T, Chen H, Lemke N, Abbott C, Qualls C, Stromberg S, Canive J, Gasparovic C.

Schizophr Bull. 2017 May 1;43(3):611-619. doi: 10.1093/schbul/sbw122.

PMID:
27550776
8.

Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.

Cecil KM, DelBello MP, Sellars MC, Strakowski SM.

J Child Adolesc Psychopharmacol. 2003 Winter;13(4):545-55.

PMID:
14977467
9.

Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.

Tiberio M, Chard DT, Altmann DR, Davies G, Griffin CM, McLean MA, Rashid W, Sastre-Garriga J, Thompson AJ, Miller DH.

J Neurol. 2006 Feb;253(2):224-30. Epub 2005 Nov 24.

PMID:
16307201
10.

Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.

Tandon N, Bolo NR, Sanghavi K, Mathew IT, Francis AN, Stanley JA, Keshavan MS.

Schizophr Res. 2013 Aug;148(1-3):59-66. doi: 10.1016/j.schres.2013.05.024. Epub 2013 Jun 20.

PMID:
23791389
11.

Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.

Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M.

Psychiatry Res. 2004 Jul 30;131(2):95-105.

PMID:
15313516
12.

In vivo quantitative proton MRSI study of brain development from childhood to adolescence.

Horská A, Kaufmann WE, Brant LJ, Naidu S, Harris JC, Barker PB.

J Magn Reson Imaging. 2002 Feb;15(2):137-43.

PMID:
11836768
13.

Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: relationship to IQ and early trauma.

Coplan JD, Mathew SJ, Mao X, Smith EL, Hof PR, Coplan PM, Rosenblum LA, Gorman JM, Shungu DC.

Psychiatry Res. 2006 Jun 30;147(1):27-39. Epub 2006 Jun 22.

PMID:
16797939
15.

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, Frank JA, Tedeschi G, Weinberger DR.

Am J Psychiatry. 1996 Dec;153(12):1554-63.

PMID:
8942451
16.

N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI.

Jakary A, Vinogradov S, Feiwell R, Deicken RF.

Schizophr Res. 2005 Jul 15;76(2-3):173-85. Epub 2005 Apr 15.

PMID:
15949650
17.

In vivo short echo time 1H-magnetic resonance spectroscopic imaging (MRSI) of the temporal lobes.

McLean MA, Woermann FG, Simister RJ, Barker GJ, Duncan JS.

Neuroimage. 2001 Aug;14(2):501-9.

PMID:
11467922
18.

Proton magnetic resonance spectroscopy of late-life major depressive disorder.

Chen CS, Chiang IC, Li CW, Lin WC, Lu CY, Hsieh TJ, Liu GC, Lin HF, Kuo YT.

Psychiatry Res. 2009 Jun 30;172(3):210-4. doi: 10.1016/j.pscychresns.2009.01.003. Epub 2009 Mar 20.

PMID:
19303260
19.

(1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.

Howells FM, Uhlmann A, Temmingh H, Sinclair H, Meintjes E, Wilson D, Stein DJ.

Schizophr Res. 2014 Mar;153(1-3):122-8. doi: 10.1016/j.schres.2014.01.029. Epub 2014 Feb 12.

PMID:
24529366
20.

Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.

Gruber S, Pinker K, Riederer F, Chmelík M, Stadlbauer A, Bittsanský M, Mlynárik V, Frey R, Serles W, Bodamer O, Moser E.

Eur J Radiol. 2008 Nov;68(2):320-7. Epub 2007 Oct 25.

PMID:
17964104

Supplemental Content

Support Center